Glycemic Efficacy and Safety of Ertugliflozin (ERTU) in Patients with Type 2 Diabetes (T2D) and Chronic Kidney Disease Stage 3 (CKD 3): An Analysis from VERTIS CVSamuel Dagogo-Jack,Richard E. Pratley,David Cherney,Bernard Charbonnel,Darren K. Mcguire,Francesco Cosentino,Weichung J. Shih,Jie Liu,Robert Frederich,James P. Mancuso,Annaswamy Raji,Ira GantzDIABETES（2021）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
